Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SILEXION THERAPEUTICS CORP (SLXN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SILEXION THERAPEUTICS CORP (SLXN), most recent 12 months reported: net loss $13.96M, free cash flow -$12.43M. Latest balance sheet on file: liquid cash $2.23M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Revolution Medicines, Inc. · SAB BIOTHERAPEUTICS, INC. · Sana Biotechnology, Inc. · Solid Biosciences Inc. · SCHOLAR ROCK HOLDING CORPORATION · Protara Therapeutics, Inc. · TECTONIC THERAPEUTIC, INC. · Instil Bio, Inc.

Stock screener

Watchlist